Advances in Single-use Bioreactor Technologies
Advances in Single-use Bioreactor Technologies offer rapid development pathways when combined with creative upstream process development strategies. When aggressive program timelines are required, the application of multiplexed conditions coupled with smart CMC decisions that maximize yields will drive the most successful biologics development solutions. Join Catalent to discuss decisions for selecting a manufacturing partner who can deliver on both a reproducible process and fast development timelines.
Learn how the following can be designed to best support aggressive timelines:
• Advanced technology
• Program management and contracting
• Process development
• Manufacturing
Catalent Biologics provides advanced technologies and integrated solutions for biological development and manufacturing translating your science from DNA to clinical supply. From cell line engineering to biopharmaceutical analysis, biomanufacturing and fill finish supply, we are the catalyst for your biologics development success.
Presented by
Rob Gustines,
Account Director, Catalent Biologics
Mr. Gustines is responsible for Catalent's Biologics Business Development activities in the Eastern U.S. He has been in the biotech industry for over 25 years working for world class biologics manufacturing companies and developers of life science tools. He has extensive knowledge in the use of mammalian expression technologies - from the lab bench through clinical development and cGMP production. In Business Development, Rob works with Catalent clients to access the GPEx® cell line technology platform and for the manufacture of their biologic drugs. He received an MBA from the Smith School of Business at the University of Maryland and a BS from Cook College at Rutgers University.
